|
CEBPG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.700940E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.761900E-02 |
| Normal-vs-Stage2 |
1.300190E-01 |
| Normal-vs-Stage3 |
1.61590000269385E-08 |
| Normal-vs-Stage4 |
2.118700E-03 |
| Stage1-vs-Stage2 |
2.774000E-02 |
| Stage1-vs-Stage3 |
2.239800E-03 |
| Stage1-vs-Stage4 |
1.121160E-01 |
| Stage2-vs-Stage3 |
7.408200E-04 |
| Stage2-vs-Stage4 |
2.782900E-03 |
| Stage3-vs-Stage4 |
8.428800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05120000004622E-06 |
| Normal-vs-AfricanAmerican |
7.11780001605433E-09 |
| Normal-vs-Asian |
2.096000E-02 |
| Caucasian-vs-AfricanAmerican |
2.178300E-02 |
| Caucasian-vs-Asian |
7.948000E-01 |
| AfricanAmerican-vs-Asian |
6.986100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.519500E-03 |
| Normal-vs-Female |
1.035690E-02 |
| Male-vs-Female |
5.276400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.415400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.351200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.496170E-01 |
| Normal-vs-Age(81-100Yrs) |
5.956200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.109400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.886400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.180200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.667400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.526000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.212800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.74130000000417E-05 |
| Classical-VS-Follicular |
2.28109999999004E-05 |
| Classical-VS-Other |
4.559900E-02 |
| Classical-VS-Normal |
1.59557999999116E-05 |
| Tall-VS-Follicular |
1.28160004830846E-09 |
| Tall-VS-Other |
5.279400E-01 |
| Tall-VS-Normal |
1.87738713464114E-12 |
| Follicular-VS-Other |
2.02260000004006E-06 |
| Follicular-VS-Normal |
1.412410E-02 |
| Other-VS-Normal |
2.2591999999988E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.986400E-01 |
| Normal-vs-N1 |
3.9655999999999E-05 |
| N0-vs-N1 |
1.503690E-03 |
|
|
